Home › Companies › LARIMAR THERAPEUTICS, INC. › 2025-2026

LARIMAR THERAPEUTICS, INC. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and LARIMAR THERAPEUTICS, INC.’s Form 8-K, filed 2026-05-19 (Item 5.07 on EDGAR). Page generated 02 October 2026.

8Reported items
150Asset managers
1,227Fund votes
2026-05-19Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore LARIMAR THERAPEUTICS, INC. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by LARIMAR THERAPEUTICS, INC.

These tallies are LARIMAR THERAPEUTICS, INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-05-19 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

LARIMAR THERAPEUTICS, INC. — official shareholder meeting results, meeting held 2026-05-19
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Frank Thomas	66,827,378	--	--	8,569,298	15,489,254	Majority: yes
Elect Director: Carole S. Ben-Maimon, M.D.	67,314,208	--	--	8,082,468	15,489,254	Majority: yes
Elect Director: Joseph Truitt	66,445,617	--	--	8,951,059	15,489,254	Majority: yes
Proposal 2 - Approval, on an advisory basis, of the compensation of the Company's named executive officers in 2025.	73,822,237	1,498,429	76,010	--	15,489,254	Majority: yes
Proposal 3: Approval, on an advisory basis, of the preferred frequency of future advisory votes on the compensation of the Company's named executive officers	90,784,651	72,972	28,307	--	0	Majority: yes
Proposal 5 - Approval of an amendment to the Ninth Amended and Restated Certificate of Incorporation, as amended.	89,732,486	1,046,555	106,889	--	0	Majority: yes
Proposal 6 - Approval of an adjournment of the Annual Meeting. The stockholders approved an adjournment of the Annual Meeting to the extent there were insufficient votes to approve Proposal 5, but such an adjournment was not necessary in li	89,887,684	958,761	39,485	--	0	Majority: yes

Source: LARIMAR THERAPEUTICS, INC., Form 8-K, filed with the SEC on 2026-05-19 — read the filing on EDGAR.

How asset managers voted at the LARIMAR THERAPEUTICS, INC. 2025-2026 meeting

Each item below shows how the 150 asset managers that disclosed a LARIMAR THERAPEUTICS, INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of LARIMAR THERAPEUTICS, INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Approval, on an Advisory Basis, of the Compensation of our Named Executive Officers.

SECTION 14A SAY-ON-PAY VOTES

Combines 2 wordings of this item as funds reported it.

99% fund support · no official result

FOR 99%

The 148 asset managers below cast 99% of the shares they voted on this item FOR (69,635,631 for, 1,019,036 against).

FOR: 69,635,631 (98.6%)AGAINST: 1,019,036 (1.4%)ABSTAIN: 3,289 (0.0%)

Largest asset managers voting on “Approval, on an Advisory Basis, of the Compensation of our Named Executive Officers.” at LARIMAR THERAPEUTICS, INC., 2025-2026
Asset manager	For	Against	Vote
DEERFIELD MANAGEMENT COMPANY, L.P.	35,606,974	0	For
Blue Owl Capital Holdings LP	7,120,007	0	For
Vanguard	3,415,413	1	For
BlackRock	3,006,173	19,070	For
DRIEHAUS CAPITAL MANAGEMENT LLC	2,130,621	0	For
DAFNA Capital Management LLC	2,029,164	0	For
RTW INVESTMENTS, LP	1,500,000	0	For
Woodline Partners LP	1,400,850	0	For
Deep Track Capital, LP	1,345,092	0	For
Logos Global Management LP	1,299,997	0	For
GEODE CAPITAL MANAGEMENT, LLC	1,106,588	0	For
Fidelity	963,469	0	For
Soleus Capital Management, L.P.	888,407	0	For
Point72	678,762	0	For
Alyeska Investment Group, L.P.	0	540,384	Against
State Street	511,882	1,659	For
Goldman Sachs	489,050	0	For
Two Sigma	440,123	0	For
Nuveen	392,709	0	For
TIAA	382,136	0	For
DE Shaw	357,050	0	For
DRIEHAUS MUTUAL FUNDS	341,778	0	For
AQR	331,747	0	For
Northern Trust	325,542	2,408	For
MARSHALL WACE, LLP	322,175	0	For

Showing the 25 largest of 148 asset managers. See all 148 in the interactive database.

2. Approval, on an Advisory Basis, of the Preferred Frequency of Future Advisory Votes on the Compensation of our Named Executive Officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%

FOR: 90,784,651AGAINST: 72,972

LARIMAR THERAPEUTICS, INC.’s own tally for this item (“Proposal 3: Approval, on an advisory basis, of the preferred frequency of future advisory votes on the compensation of the Company's named executive officers”): 90,784,651 for, 72,972 against, per its Form 8-K filed 2026-05-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 103,882,937 outstanding shares: 87% for, 0.1% against (87% of the company cast a for/against vote).

The 148 asset managers below cast 100% of the shares they voted on this item FOR (82,121 for, 0 against).

1 YEAR 72%ONE YEAR 22%

FOR: 82,121 (0.1%)ABSTAIN: 5,289 (0.0%)1 YEAR: 51,609,646 (72.3%)ONE YEAR: 15,990,069 (22.4%)3: 2,139,879 (3.0%)1-YEAR: 1,299,997 (1.8%)THREE YEARS: 232,178 (0.3%)1.0: 36,044 (0.1%)3 YEARS: 1,759 (0.0%)3.0: 2 (0.0%)

Largest asset managers voting on “Approval, on an Advisory Basis, of the Preferred Frequency of Future Advisory Votes on the Compensation of our” at LARIMAR THERAPEUTICS, INC., 2025-2026
Asset manager	For	Against	Abstain	Withheld	Vote
DEERFIELD MANAGEMENT COMPANY, L.P.	0	0	0	0	1 Year
Blue Owl Capital Holdings LP	0	0	0	0	1 Year
Vanguard	0	0	0	0	One Year
BlackRock	0	0	0	0	1 Year
AIGH Capital Management LLC	0	0	0	0	3
DRIEHAUS CAPITAL MANAGEMENT LLC	0	0	0	0	One Year
DAFNA Capital Management LLC	0	0	0	0	1 Year
RTW INVESTMENTS, LP	0	0	0	0	One Year
Deep Track Capital, LP	0	0	0	0	1 Year
Logos Global Management LP	0	0	0	0	1-Year
GEODE CAPITAL MANAGEMENT, LLC	0	0	0	0	One Year
Fidelity	0	0	0	0	One Year
Soleus Capital Management, L.P.	0	0	0	0	1 Year
Point72	0	0	0	0	One Year
Alyeska Investment Group, L.P.	0	0	0	0	One Year
State Street	0	0	0	0	One Year
Goldman Sachs	0	0	0	0	One Year
Two Sigma	0	0	0	0	One Year
Nuveen	0	0	0	0	One Year
TIAA	0	0	0	0	One Year
DE Shaw	0	0	0	0	One Year
DRIEHAUS MUTUAL FUNDS	0	0	0	0	One Year
AQR	0	0	0	0	One Year
Northern Trust	0	0	0	0	1 Year
MARSHALL WACE, LLP	0	0	0	0	1 Year

Showing the 25 largest of 148 asset managers. See all 148 in the interactive database.

3. APPROVAL OF AN ADJOURNMENT OF THE ANNUAL MEETING TO THE EXTENT THERE ARE INSUFFICIENT VOTES AT THE ANNUAL MEETING TO APPROVE PROPOSAL 5.

CORPORATE GOVERNANCEMajority of the votes cast: yes

99% Majority: yes · of votes cast

FOR 99%

FOR: 89,887,684AGAINST: 958,761

LARIMAR THERAPEUTICS, INC.’s own tally for this item (“Proposal 6 - Approval of an adjournment of the Annual Meeting. The stockholders approved an adjournment of the Annual Meeting to the extent there were insufficient votes to approve Proposal 5, but such an adjournment was”): 89,887,684 for, 958,761 against, per its Form 8-K filed 2026-05-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 103,882,937 outstanding shares: 87% for, 1.0% against (87% of the company cast a for/against vote).

The 45 asset managers below cast 99.2% of the shares they voted on this item FOR (8,017,102 for, 60,592 against).

FOR 99.2%

FOR: 8,017,102 (99.2%)AGAINST: 60,592 (0.8%)

Largest asset managers voting on “APPROVAL OF AN ADJOURNMENT OF THE ANNUAL MEETING TO THE EXTENT THERE ARE INSUFFICIENT VOTES AT THE ANNUAL MEET” at LARIMAR THERAPEUTICS, INC., 2025-2026
Asset manager	For	Against	Vote
Vanguard	3,097,154	0	For
BlackRock	1,667,483	0	For
Fidelity	950,715	0	For
TIAA	382,136	0	For
DRIEHAUS MUTUAL FUNDS	341,778	0	For
Goldman Sachs	329,463	0	For
RBB FUND, INC.	164,782	0	For
JPMorgan	158,582	0	For
Charles Schwab	145,342	0	For
Equitable	123,236	0	For
Dimensional	118,232	0	For
QUANTITATIVE MASTER SERIES LLC	70,068	0	For
Brighthouse	68,945	0	For
Brinker Capital Destinations Trust	57,080	1,737	For
AIG/SunAmerica	52,185	0	For
Nationwide	40,029	0	For
BRIDGEWAY FUNDS INC	34,916	0	For
Lincoln Financial	0	31,200	Against
Federated Hermes	29,257	0	For
SEI	24,922	0	For
Global X	23,043	0	For
American Century	20,071	0	For
Bridge Builder Trust	19,843	0	For
Pacific Life	19,632	0	For
State Street	0	16,546	Against

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.

4. APPROVAL OF AN AMENDMENT TO OUR NINTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION, AS AMENDED, TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF OUR COMMON STOCK FROM 115,000,000 TO 215,000,000.

CAPITAL STRUCTUREMajority of the votes cast: yes

99% Majority: yes · of votes cast

FOR 99%

FOR: 89,732,486AGAINST: 1,046,555

LARIMAR THERAPEUTICS, INC.’s own tally for this item (“Proposal 5 - Approval of an amendment to the Ninth Amended and Restated Certificate of Incorporation, as amended.”): 89,732,486 for, 1,046,555 against, per its Form 8-K filed 2026-05-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 103,882,937 outstanding shares: 86% for, 1% against (87% of the company cast a for/against vote).

The 45 asset managers below cast 100% of the shares they voted on this item FOR (8,077,694 for, 0 against).

FOR 100%

FOR: 8,077,694 (100.0%)

Largest asset managers voting on “APPROVAL OF AN AMENDMENT TO OUR NINTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION, AS AMENDED, TO INCREA” at LARIMAR THERAPEUTICS, INC., 2025-2026
Asset manager	For	Vote
Vanguard	3,097,154	For
BlackRock	1,667,483	For
Fidelity	950,715	For
TIAA	382,136	For
DRIEHAUS MUTUAL FUNDS	341,778	For
Goldman Sachs	329,463	For
RBB FUND, INC.	164,782	For
JPMorgan	158,582	For
Charles Schwab	145,342	For
Equitable	123,236	For
Dimensional	118,232	For
QUANTITATIVE MASTER SERIES LLC	70,068	For
Brighthouse	68,945	For
Brinker Capital Destinations Trust	58,817	For
AIG/SunAmerica	52,185	For
Nationwide	40,029	For
BRIDGEWAY FUNDS INC	34,916	For
Lincoln Financial	31,200	For
Federated Hermes	29,257	For
SEI	24,922	For
Global X	23,043	For
American Century	20,071	For
Bridge Builder Trust	19,843	For
Pacific Life	19,632	For
State Street	16,546	For

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.

5. Election of Class III Directors for a Three-Year Term Expiring in 2029: Carole S. Ben-Maimon, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

89% Majority: yes · of votes cast

FOR 89%11%

FOR: 67,314,208WITHHELD: 8,082,468

LARIMAR THERAPEUTICS, INC.’s own tally for this item (“Elect Director: Carole S. Ben-Maimon, M.D.”): 67,314,208 for, 8,082,468 withheld, per its Form 8-K filed 2026-05-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 103,882,937 outstanding shares: 65% for, 8% withheld (73% of the company cast a for/withheld vote).

The 45 asset managers below cast 100% of the shares they voted on this item FOR (7,219,909 for, 0 against).

FOR 89%11%

FOR: 7,219,909 (89.4%)ABSTAIN: 857,785 (10.6%)

Largest asset managers voting on “Election of Class III Directors for a Three-Year Term Expiring in 2029: Carole S. Ben-Maimon, M.D.” at LARIMAR THERAPEUTICS, INC., 2025-2026
Asset manager	For	Abstain	Vote
Vanguard	3,094,152	3,002	For
BlackRock	1,667,483	0	For
Fidelity	950,715	0	For
TIAA	382,136	0	For
DRIEHAUS MUTUAL FUNDS	0	341,778	Abstain
Goldman Sachs	329,463	0	For
RBB FUND, INC.	0	164,782	Abstain
JPMorgan	158,582	0	For
Charles Schwab	145,342	0	For
Equitable	123,236	0	For
Dimensional	0	118,232	Abstain
QUANTITATIVE MASTER SERIES LLC	70,068	0	For
Brighthouse	53,453	15,492	For
Brinker Capital Destinations Trust	1,737	57,080	Abstain
AIG/SunAmerica	0	52,185	Abstain
Nationwide	40,029	0	For
BRIDGEWAY FUNDS INC	0	34,916	Abstain
Lincoln Financial	31,200	0	For
Federated Hermes	29,257	0	For
SEI	24,922	0	For
Global X	23,043	0	For
American Century	0	20,071	Abstain
Bridge Builder Trust	19,843	0	For
Pacific Life	19,632	0	For
State Street	16,546	0	For

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.

6. Election of Class III Directors for a Three-Year Term Expiring in 2029: Frank Thomas

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

89% Majority: yes · of votes cast

FOR 89%11%

FOR: 66,827,378WITHHELD: 8,569,298

LARIMAR THERAPEUTICS, INC.’s own tally for this item (“Elect Director: Frank Thomas”): 66,827,378 for, 8,569,298 withheld, per its Form 8-K filed 2026-05-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 103,882,937 outstanding shares: 64% for, 8% withheld (73% of the company cast a for/withheld vote).

The 45 asset managers below cast 100% of the shares they voted on this item FOR (6,790,824 for, 0 against).

FOR 84%ABSTAIN 16%

FOR: 6,790,824 (84.1%)ABSTAIN: 1,286,870 (15.9%)

Largest asset managers voting on “Election of Class III Directors for a Three-Year Term Expiring in 2029: Frank Thomas” at LARIMAR THERAPEUTICS, INC., 2025-2026
Asset manager	For	Abstain	Vote
Vanguard	3,092,753	4,401	For
BlackRock	1,667,483	0	For
Fidelity	950,715	0	For
TIAA	0	382,136	Abstain
DRIEHAUS MUTUAL FUNDS	0	341,778	Abstain
Goldman Sachs	329,463	0	For
RBB FUND, INC.	0	164,782	Abstain
JPMorgan	158,582	0	For
Charles Schwab	145,342	0	For
Equitable	77,686	45,550	For
Dimensional	0	118,232	Abstain
QUANTITATIVE MASTER SERIES LLC	70,068	0	For
Brighthouse	53,453	15,492	For
Brinker Capital Destinations Trust	1,737	57,080	Abstain
AIG/SunAmerica	0	52,185	Abstain
Nationwide	40,029	0	For
BRIDGEWAY FUNDS INC	0	34,916	Abstain
Lincoln Financial	31,200	0	For
Federated Hermes	29,257	0	For
SEI	24,922	0	For
Global X	23,043	0	For
American Century	0	20,071	Abstain
Bridge Builder Trust	19,843	0	For
Pacific Life	19,632	0	For
State Street	16,546	0	For

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.

7. Election of Class III Directors for a Three-Year Term Expiring in 2029: Joseph Truitt

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

88% Majority: yes · of votes cast

FOR 88%12%

FOR: 66,445,617WITHHELD: 8,951,059

LARIMAR THERAPEUTICS, INC.’s own tally for this item (“Elect Director: Joseph Truitt”): 66,445,617 for, 8,951,059 withheld, per its Form 8-K filed 2026-05-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 103,882,937 outstanding shares: 64% for, 9% withheld (73% of the company cast a for/withheld vote).

The 45 asset managers below cast 100% of the shares they voted on this item FOR (6,773,025 for, 0 against).

FOR 84%ABSTAIN 16%

FOR: 6,773,025 (83.8%)ABSTAIN: 1,304,669 (16.2%)

Largest asset managers voting on “Election of Class III Directors for a Three-Year Term Expiring in 2029: Joseph Truitt” at LARIMAR THERAPEUTICS, INC., 2025-2026
Asset manager	For	Abstain	Vote
Vanguard	3,092,753	4,401	For
BlackRock	1,667,483	0	For
Fidelity	950,715	0	For
TIAA	0	382,136	Abstain
DRIEHAUS MUTUAL FUNDS	0	341,778	Abstain
Goldman Sachs	329,463	0	For
RBB FUND, INC.	0	164,782	Abstain
JPMorgan	158,582	0	For
Charles Schwab	145,342	0	For
Equitable	77,686	45,550	For
Dimensional	0	118,232	Abstain
QUANTITATIVE MASTER SERIES LLC	70,068	0	For
Brighthouse	53,453	15,492	For
Brinker Capital Destinations Trust	1,737	57,080	Abstain
AIG/SunAmerica	0	52,185	Abstain
Nationwide	40,029	0	For
BRIDGEWAY FUNDS INC	0	34,916	Abstain
Lincoln Financial	31,200	0	For
Federated Hermes	29,257	0	For
SEI	24,922	0	For
Global X	23,043	0	For
American Century	0	20,071	Abstain
Bridge Builder Trust	19,843	0	For
Pacific Life	19,632	0	For
State Street	16,546	0	For

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.

8. Ratification of Appointment of PricewaterhouseCoopers LLP as our Independent Registered Public Accounting Firm for the 2026 Fiscal Year.

AUDIT-RELATED

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 45 asset managers below cast 100% of the shares they voted on this item FOR (8,077,694 for, 0 against).

FOR: 8,077,694 (100.0%)

Largest asset managers voting on “Ratification of Appointment of PricewaterhouseCoopers LLP as our Independent Registered Public Accounting Firm” at LARIMAR THERAPEUTICS, INC., 2025-2026
Asset manager	For	Vote
Vanguard	3,097,154	For
BlackRock	1,667,483	For
Fidelity	950,715	For
TIAA	382,136	For
DRIEHAUS MUTUAL FUNDS	341,778	For
Goldman Sachs	329,463	For
RBB FUND, INC.	164,782	For
JPMorgan	158,582	For
Charles Schwab	145,342	For
Equitable	123,236	For
Dimensional	118,232	For
QUANTITATIVE MASTER SERIES LLC	70,068	For
Brighthouse	68,945	For
Brinker Capital Destinations Trust	58,817	For
AIG/SunAmerica	52,185	For
Nationwide	40,029	For
BRIDGEWAY FUNDS INC	34,916	For
Lincoln Financial	31,200	For
Federated Hermes	29,257	For
SEI	24,922	For
Global X	23,043	For
American Century	20,071	For
Bridge Builder Trust	19,843	For
Pacific Life	19,632	For
State Street	16,546	For

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.

Largest LARIMAR THERAPEUTICS, INC. shareholders voting in 2025-2026

Ranked by the number of LARIMAR THERAPEUTICS, INC. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 103,882,937 shares outstanding at the time of that meeting.

Top LARIMAR THERAPEUTICS, INC. shareholders by shares voted, 2025-2026
#	Asset manager	% of shares outstanding
1	DEERFIELD MANAGEMENT COMPANY, L.P.	34.28%
2	Blue Owl Capital Holdings LP	6.85%
3	Vanguard	3.29%
4	BlackRock	2.91%
5	DRIEHAUS CAPITAL MANAGEMENT LLC	2.05%
6	DAFNA Capital Management LLC	1.95%
7	RTW INVESTMENTS, LP	1.44%
8	Woodline Partners LP	1.35%
9	Deep Track Capital, LP	1.29%
10	Logos Global Management LP	1.25%

Reported LARIMAR THERAPEUTICS, INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

LARIMAR THERAPEUTICS, INC. beneficial owners on record for the 2025-2026 proxy season
Holder	% outstanding	Disclosure
Deerfield Management Company, L.P.	34.33%	13D
BlackRock	3.61%	13F
Millennium Management	3.49%	13F
Vanguard Group	2.93%	13F
Goldman Sachs	1.59%	13F
Geode Capital	1.07%	13F
Point72	1.01%	13F
State Street	0.88%	13F
Dimensional Fund Advisors	0.77%	13F
Renaissance Technologies	0.71%	13F

Percentages above are of 103,882,937 shares outstanding, as reported by LARIMAR THERAPEUTICS, INC. on its Form 10-Q dated 2026-05-12 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from LARIMAR THERAPEUTICS, INC.’s 10-Q dated 2026-05-12. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At LARIMAR THERAPEUTICS, INC.'s shareholder meeting held 2026-05-19, in the 2025-2026 proxy season, 150 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,227 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. LARIMAR THERAPEUTICS, INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — Approval, on an Advisory Basis, of the Compensation of our Named Executive Officers. — the reporting funds cast 99% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

LARIMAR THERAPEUTICS, INC. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).